These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 212736)

  • 41. beta-Lactamase inhibition by 6 alpha-thiocyanatopenicillanic acids.
    Gunda TE; Punyiczki M
    J Antibiot (Tokyo); 1982 Mar; 35(3):367-8. PubMed ID: 6281227
    [No Abstract]   [Full Text] [Related]  

  • 42. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP; Aplin RT; Schofield CJ
    Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Penicillanic acid sulfone: an unexpected isotope effect in the interaction of 6 alpha- and 6 beta-monodeuterio and of 6,6-dideuterio derivatives with RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1981 Jun; 20(13):3680-7. PubMed ID: 6268140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Development of beta-lactamase inhibitors].
    Hyodo A; Higashitani F; Nishida K; Kunugita C; Unemi N
    Nihon Rinsho; 1997 May; 55(5):1272-80. PubMed ID: 9155186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and beta-lactamase inhibitory activity of new 6beta-cysteinesulfonamidopenicillanic acids.
    Changov LS; Naydenova ED; Ivanova GI; Gergova RT; Keuleyan EE; Aleksiev BV
    Bioorg Med Chem; 1999 Dec; 7(12):2899-904. PubMed ID: 10658594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (6R)-6-(substituted methyl)penicillanic acid sulfones: new potent beta-lactamase inhibitors.
    Adam S; Then R; Angehrn P
    J Antibiot (Tokyo); 1993 Apr; 46(4):641-6. PubMed ID: 8388871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of inactivation of TEM-1 beta-lactamase by 6-acetylmethylenepenicillanic acid.
    Arisawa M; Adam S
    Biochem J; 1983 May; 211(2):447-54. PubMed ID: 6307281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 6-beta-Iodopenicillanate as a probe for the classification of beta-lactamases.
    De Meester F; Frère JM; Waley SG; Cartwright SJ; Virden R; Lindberg F
    Biochem J; 1986 Nov; 239(3):575-80. PubMed ID: 3030266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Site-specific introduction of an electroactive label into a non-electroactive enzyme (beta-lactamase I).
    Di Gleria K; Halliwell CM; Jacob C; Hill HA
    FEBS Lett; 1997 Jan; 400(2):155-7. PubMed ID: 9001388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thiol-beta-lactamase: replacement of the active-site serine of RTEM beta-lactamase by a cysteine residue.
    Sigal IS; Harwood BG; Arentzen R
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7157-60. PubMed ID: 6818541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
    Reading C; Farmer T
    Biochem J; 1981 Dec; 199(3):779-87. PubMed ID: 7041890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.
    Kemal C; Knowles JR
    Biochemistry; 1981 Jun; 20(13):3688-95. PubMed ID: 6268141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The reversible deactivation of beta-lactamase from Staphylococcus aureus by quinacillin and cephaloridine and its modification by antibodies.
    Carrey EA; Virden R; Pain RH
    Biochim Biophys Acta; 1984 Mar; 785(3):104-10. PubMed ID: 6200139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    London N; Thomson CJ; Amyes SG; Stobberingh E
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.
    Mariotte-Boyer S; Nicolas-Chanoine MH; Labia R
    FEMS Microbiol Lett; 1996 Sep; 143(1):29-33. PubMed ID: 8807798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
    Lin S; Thomas M; Shlaes DM; Rudin SD; Knox JR; Anderson V; Bonomo RA
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Irreversible inactivation of beta-lactamase I from Bacillus cereus by chlorinated 6-spiroepoxypenicillins.
    Gledhill L; Williams P; Bycroft BW
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):801-7. PubMed ID: 1905929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 6-(E)-acetylmethylenepenicillanic acid, a potent beta-lactamase inhibitor.
    Adam S; Then RL; Angehrn P
    J Antibiot (Tokyo); 1987 Jan; 40(1):108-9. PubMed ID: 3030991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.